Background: existing trials on the role of clinical pharmacists in managing chronic disease
patients have focused on variety of interventions, including preparing patients for the …

Acute coronary syndrome (ACS) is a complex clinical syndrome that encompasses acute
myocardial infarction (AMI) and unstable angina (UA). Its underlying mechanism refers to …

Anticoagulant therapy is commonly associated with a high incidence of avoidable adverse
events, especially in the acute care setting. This has led to several initiatives by key national …

Background and objectives: Secondary prevention after acute coronary syndrome (ACS) is
essential to reduce cardiovascular mortality and hospital readmission, ensuring patients …

Severe dysfunction in cardiac muscle intracellular Ca 2+ handling is a common pathway
underlying heart failure. Here we used an inducible genetic model of severe Ca 2+ cycling …

Heart failure (HF) is a clinical syndrome with signs and symptoms that result from any
structural or functional deterioration of ventricular filling or ejection of blood. It is the final …

Introduction: One of the major global risk factors for cardiovascular morbidity and death is
hypertension. Earlier research has been conducted on the connection between calcium …

Heart failure (HF) is characterized as a multifaceted condition wherein individuals present
with clinical warning signs associated with abnormalities in either the structure or function of …

Trisomy 16, responsible for 1-2% of first-trimester losses, poses diagnostic dilemmas in
reproductive medicine. While total trisomy 16 is typically lethal, mosaic trisomy 16 cases …

Thus, advances in computer models for pre-screening pharmacokinetic properties of novel
compounds allow for more predictive computer models, saving money and time in the …